Taiyen Biotech Co Ltd (1737) — Cash Flow Reinvestment Rate
Taiyen Biotech Co Ltd (1737) has a Cash Flow Reinvestment Rate of 0.38x as of June 2026, reinvesting NT$38.03 Million (capex NT$38.03 Million ) from operating cash flow of NT$99.80 Million. See Taiyen Biotech Co Ltd (1737) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Taiyen Biotech Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Taiyen Biotech Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 1737 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Taiyen Biotech Co Ltd. See 1737 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | NT$328.17 Million | NT$473.77 Million | NT$300.16 Million | ▲ +42.1% |
| 2024 | 0.49x | NT$321.68 Million | NT$660.12 Million | NT$307.61 Million | ▼ -67.6% |
| 2023 | 1.51x | NT$684.43 Million | NT$454.54 Million | NT$345.13 Million | ▲ +252.8% |
| 2022 | 0.43x | NT$247.87 Million | NT$580.69 Million | NT$246.60 Million | ▼ -39.0% |
| 2021 | 0.70x | NT$419.61 Million | NT$600.08 Million | NT$390.81 Million | ▼ -11.8% |
| 2020 | 0.79x | NT$269.06 Million | NT$339.36 Million | NT$267.89 Million | ▼ -36.3% |
| 2019 | 1.24x | NT$411.65 Million | NT$330.81 Million | NT$284.25 Million | ▲ +63.1% |
| 2018 | 0.76x | NT$343.19 Million | NT$449.83 Million | NT$298.49 Million | ▼ -16.0% |
| 2017 | 0.91x | NT$551.88 Million | NT$607.87 Million | NT$369.68 Million | ▲ +6.9% |
| 2016 | 0.85x | NT$482.65 Million | NT$568.06 Million | NT$190.30 Million | ▲ +130.0% |
| 2015 | 0.37x | NT$141.84 Million | NT$383.93 Million | NT$106.57 Million | ▼ -54.5% |
| 2014 | 0.81x | NT$300.97 Million | NT$371.06 Million | NT$148.81 Million | ▼ -34.1% |
| 2013 | 1.23x | NT$250.23 Million | NT$203.21 Million | NT$93.53 Million | ▲ +73.8% |
| 2012 | 0.71x | NT$109.40 Million | NT$154.46 Million | NT$109.40 Million | ▲ +126.8% |
| 2011 | 0.31x | NT$76.85 Million | NT$246.09 Million | NT$76.85 Million | ▼ -25.5% |
| 2010 | 0.42x | NT$126.08 Million | NT$300.89 Million | NT$126.08 Million | ▲ +30.8% |
| 2009 | 0.32x | NT$114.67 Million | NT$358.02 Million | NT$114.67 Million | ▼ -30.4% |
| 2008 | 0.46x | NT$192.08 Million | NT$417.51 Million | NT$192.08 Million | ▲ +86.2% |
| 2007 | 0.25x | NT$79.70 Million | NT$322.49 Million | NT$79.70 Million | ▼ -22.9% |
| 2006 | 0.32x | NT$148.45 Million | NT$462.88 Million | NT$148.45 Million | ▲ +43.0% |
| 2005 | 0.22x | NT$129.19 Million | NT$575.91 Million | NT$129.19 Million | ▲ +229.6% |
| 2004 | 0.07x | NT$192.93 Million | NT$2.84 Billion | NT$192.93 Million | ▲ +146.5% |
| 2003 | 0.03x | NT$94.39 Million | NT$3.42 Billion | NT$94.39 Million | — |